C. Nadler, A. Nadler, C. Hansen, U. Diederichsen
FULL PAPER
and INOVA-600). Chemical shifts are reported in ppm (for TMS,
δ = 0 ppm), and coupling constants JX,X are reported in Hz. ESI
3-Methoxy-6-nitro-2-(tritylthio)benzaldehyde (1): NaH (60% sus-
pension in mineral oil, 144 mg, 3.67 mmol, 1.00 equiv.) was added
n
mass spectra were recorded with Finnigan LCQ 7000 and Bruker
micrOTOF spectrometers. High resolution ESI spectra were ob-
tained with a Bruker APEX-Q IV 7T or Bruker micrOTOF spec-
trometer. LC–MS measurements were conducted on a Thermo Fin-
nigan LCQ ion trap mass spectrometer connected to a JASCO 851
autosampler with a Rheos 4000 pump and a Thermo Finnigan
Surveyor PDA (photodiode array) detector. Reactions were ana-
to a solution of triphenylmethanethiol (1.00 g, 3.67 mmol,
1.00 equiv.) in dry NMP (20 mL) at 0 °C under argon, and the mix-
ture was stirred at this temperature for 10 min. Compound 4
(1.29 g, 3.67 mmol, 1.00 equiv.) was added in portions, and the re-
action mixture was stirred for an additional 15 min. The reaction
was quenched by the addition of a saturated NH4Cl solution, and
the solution was diluted with Et2O (200 mL) and 1% HCl solution
(200 mL). The phases were separated, and the organic layer was
washed with H2O (3ϫ 200 mL) and brine (3ϫ 200 mL) and dried
with Na2SO4. The solvent was removed under reduced pressure,
lyzed on
a
Phenomenex Synergi LC Column, RP-C12
(150ϫ2.0 mm, 4 μm, 80 Å) or a MN Nucleodur EC column, RP-
C18, (100ϫ2.0 mm, 3 μm, 110 Å) with a linear gradient of eluent
A (H2O, 0.05% formic acid) to B (MeOH, 0.05% formic acid) in and after purification of the resulting residue by flash chromatog-
15 min. The conversions of the ligation reactions were calculated
by comparing the LC peak areas of the auxiliary peptide (starting
material) and the product that contained the auxiliary at 400 nm.
Origin[32] was used for all calculations employing a polynomial
baseline.
raphy (pentane/EtOAc, 2:1), 1 (519 mg, 1.47 mmol, 40%) was ob-
1
tained as a yellow solid. H NMR (301 MHz, CDCl3, 35 °C): δ =
3
9.53 (s, 1 H, CHO), 7.99 (d, JH,H = 9.2 Hz, 1 H, 5-H), 7.41–7.30
(m, 6 H, Trt-H), 7.30–7.12 (m, 9 H, Trt-H), 6.63 (d, 3JH,H = 9.2 Hz,
1 H, 4-H), 3.44 (s, 3 H, OCH3) ppm. 13CNMR (126 MHz, CDCl3,
27 °C): δ = 190.14 (CHO), 165.76 (C-3), 144.04 (C-6), 143.84 (Trt-
Cq), 139.14 (C-1), 130.16 (Trt-CH), 127.92 (C-5), 127.41 (Trt-CH),
127.10 (Trt-CH), 122.02 (C-2), 110.50 (C-4), 73.57 (SCPh3), 55.78
(OCH3) ppm. MS (ESI): m/z (rel. %) = 478.1 (100) [M + Na]+, 933
(93) [2M + Na]+. HRMS (ESI): calcd. for: [C27H21NO4SNa]+ [M
+ Na]+ 478.1083; found 478.1073; calcd. for [C27H20NO4S]– [M –
H]– 454.1119; found 454.1114. UV (MeCN): λmax = 229, 303 nm.
3-Methoxy-2-p-tolylsulfonylbenzaldehyde (5): o-Vanillin (2, 10.0 g,
65.8 mmol, 1.00 equiv.) and KOH (4.00 g, 70.1 mmol, 1.07 equiv.)
were dissolved in H2O (70 mL). Tosyl chloride (12.5 g, 65.8 mmol,
1.00 equiv.) was added, and the mixture was stirred at room tem-
perature for 1 h. DCM (5 mL) was added, and the precipitate was
removed by filtration, washed with H2O (3ϫ 100 mL), and dried
under reduced pressure to yield the crude product (19.0 g,
1
62.0 mmol, 94%), which was used without further purification. H
Peptide Synthesis: Except for the peptide thioesters, all peptides
were synthesized by manual Fmoc solid-phase peptide synthesis on
preloaded Wang resins by using O-(benzotriazol-1-yl)-N,N,NЈ,NЈ-
tetramethyluronium hexafluorophosphate (HBTU)/ 1-hydroxy-
benzotriazole (HOBt)/N,N-diisopropylethylamine (DIPEA) as the
coupling agents and applying a fivefold excess amount of the acti-
vated Fmoc-protected amino acids in NMP. The last Fmoc group
was retained on the peptide for storage purposes and removed by
the standard protocol shortly before functionalization. The resins
were dried in vacuo overnight before functionalization.
NMR (300 MHz, CDCl3, 29 °C): δ = 10.09 (s, 1 H, CHO), 7.84–
7.71 (m, 2 H, Tos-HAr), 7.55–7.44 (m, 1 H, 5/6-H), 7.44–7.24 (m,
3 H, Tos-HAr and 5/6-H), 7.11 (dd, 3JH,H = 8.2 Hz, 4JH,H = 1.5 Hz,
1 H, 4-H), 3.59 (s, 3 H, OCH3), 2.47 (s, 3 H, Tos-CH3) ppm. 13C
NMR (126 MHz, CDCl3, 27 °C): δ = 188.10 (C=O), 152.72 (C-3),
145.85 (C-2), 132.79 (CTos-4), 131.34 (CTos-1), 129.79 (CTos-2/6),
128.74 (CTos-3/5), 128.00 (C-6), 119.54 (C-5), 118.08 (C-4), 56.06
(OCH3), 21.86 (Tos-CH3) ppm. MS (ESI): m/z (rel. %) = 307.1 (6)
[M + H]+, 329.1 (100) [M + Na]+, 635.1 (56) [2M + Na]+. HRMS
(ESI): calcd. for [C15H15O5S]+ [M + H]+ 307.0635; found 307.0638;
calcd. for [C15H14O5SNa]+ [M + Na]+ 329.0454; found 329.0455;
calcd. for [C15H13O5S]– [M – H]– 305.0489; found 305.0485.
Attachment of Auxiliary 1 to Peptides: The resin (20.0 mg, resin
load: 0.2–0.4 mmolg–1) was suspended in anhydrous DCM (2 mL)
3-Methoxy-6-nitro-2-(p-tolylsulfonyl)benzaldehyde (4): Benzalde- under argon over activated molecular sieves (3 Å). The suspension
hyde 4 was synthesized according to a reported protocol for the
corresponding phenylsulfonyl derivative.[24] 3-Methoxy-2-(p-tolyl-
sulfonyl)benzaldehyde (5, 18.1 g, 59.2 mmol, 1.00 equiv.) was added
to 90% HNO3 (42 mL) at 0 °C over the course of 30 min. After
additional stirring for 30 min, the mixture was poured onto ice
(240 g), and the mixture was warmed to room temperature. The
resulting precipitate was collected by filtration and washed with
H2O (50 mL). The solid was suspended in acetone, and was kept
at 4 °C for 20 h. The solvent was removed by filtration and the
crude product purified by flash chromatography (pentane/EtOAc,
was stirred for 1 h to allow the resin to swell. Auxiliary 1
(10.0 equiv.) was dissolved in anhydrous DCM (1 mL) under argon
and transferred to the suspension. After the addition of
NaBH(OAc)3 (25.0 equiv.), the suspension was stirred at room tem-
perature for 24 h with the exclusion of light. The suspension was
subsequently transferred into a test tube and diluted with DCM
(25 mL). Molecular sieves and the boron compounds were sepa-
rated from the resin by sedimentation (15 min). The resin, which
rose to the surface, was pipetted into a BD syringe, washed with
DCM (5ϫ 1 mL), and dried in vacuo overnight. A mixture of TFA/
4:1) to yield the product (12.6 g, 35.9 mmol, 60%) as a yellow solid. TES/H2O (95:2.5:2.5, 1 mL) was added to the dry resin, and the
1H NMR (300 MHz, CDCl3, 29 °C): δ = 10.08 (s, 1 H, CHO), 8.15 mixture was agitated at room temperature for 30 min with the ex-
3
(d, JH,H = 9.2 Hz, 1 H, 5-H), 7.86–7.75 (m, 2 H, Tos-HAr), 7.44– clusion of light. The solution was transferred into a lightproof
7.33 (m, 2 H, Tos-HAr), 7.07 (d, 3JH,H = 9.3 Hz, 1 H, 4-H), 3.78 (s, flask, and the resin was washed with TFA (2ϫ 1 mL). The solvent
3 H, OCH3), 2.49 (s, 3 H, Tos-CH3) ppm. 13C NMR (126 MHz, was removed under reduced pressure, and the resulting solid was
CDCl3, 27 °C): δ = 185.89 (CHO), 157.96 (C-3), 146.14 (CTos-4), suspended in cold Et2O (12 mL) and precipitated by centrifugation
139.45 (C-6), 135.15 (C-1), 132.49 (CTos-1), 131.93 (C-2), 129.81 at –20 °C and 9000 min–1 for 30 min. The solvent was decanted,
(CTos-2/6), 128.64 (CTos-3/5), 124.98 (C-4), 113.16 (C-5), 56.85 and the crude product was dissolved in a mixture of H2O and
(OCH3), 21.96 (Tos-CH3) ppm. MS (ESI): m/z (rel. %) = 352.1 (37)
MeCN (1:1). The resulting solution was lyophilized and purified
[M + H]+, 374.1 (95) [M + Na]+, 725.1 (100) [2M + Na]+. HRMS by reverse phase HPLC. The auxiliary peptides were obtained in
(ESI): calcd. for [C15H14NO5S]+ [M + H]+ 352.0485; found
352.0483; calcd. for [C15H13NO5SNa]+ [M + Na]+ 374.0305; found
isolated yields of up to 39% based on resin loading (included pept-
ide synthesis, reductive amination, cleavage from the resin, and
374.0305; calcd. for: [C15H12NO5S]– [M – H]– 350.0340; found HPLC purification). All products were isolated in their oxidized
350.0328.
form.
3100
www.eurjoc.org
© 2015 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2015, 3095–3102